Description
Walrycin B inhibits the walrycin response regulator (WalR). This compound exhibits antibacterial activity, altering cell wall metabolism and cell division in Bacillus and Staphylococcus.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Walrycin B inhibits the walrycin response regulator (WalR). This compound exhibits antibacterial activity, altering cell wall metabolism and cell division in Bacillus and Staphylococcus.
| Cas No. | 878419-78-4 |
|---|---|
| Purity | ≥98% |
| Formula | C14H10F3N5O2 |
| Formula Wt. | 337.26 |
| IUPAC Name | 1,6-Dimethyl-3-[4-(trifluoromethyl)phenyl]pyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione |
| Solubility | DMSO: 11.5 mg/mL |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Gotoh Y, Doi A, Furuta E, et al. Novel antibacterial compounds specifically targeting the essential WalR response regulator. J Antibiot (Tokyo). 2010 Mar;63(3):127-34. PMID: 20111065.
Fluoroquinolone; topoisomerase IV and bacterial...
Aspirin analog; hemoglobin chain cross-linker.<...
D2 and D4 dopamine receptor inhibitor.
Endogenous peptide hormone, involved in cell gr...
Mycotoxin found in Aspergillus and Penicillum; ...
RAD51 inhibitor.
NS3/4A inhibitor
Endogenous quaternary ammonium, required for fa...
Peptide, urocortin III analog; CRFR2 agonist.
Pyrimidine nucleoside (cytidine) analog; DNA ch...
Vitamin D analog.
Naturally produced ITC, sulfonyl analog of sulf...
Antioxidant, vitamin E derivative found in vege...
VEGFR inhibitor.
Deubiquitinating enzyme inhibitor.
Lck, Src, SIK inhibitor.
Synthetic ITC.
Dipeptide; aminopeptidase (N/CD13) inhibitor.
Endogenous pterin coenzyme required for release...